Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Galena Biopharma Inc    GALE

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/26/2015 08/27/2015 08/28/2015 08/31/2015 09/01/2015 Date
1.49(c) 1.49(c) 1.5(c) 1.58(c) 1.58(c) Last
2 458 154 1 058 310 1 100 497 1 410 992 1 781 694 Volume
-7.45% 0.00% +0.67% +5.33% 0.00% Change
More quotes
Financials ($)
Sales 2015 15,3 M
EBIT 2015 -44,4 M
Net income 2015 -49,4 M
Debt 2015 -
Yield 2015 -
Sales 2016 29,4 M
EBIT 2016 -35,9 M
Net income 2016 -38,3 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 16,7x
Capi. / Sales 2016 8,70x
Capitalization 256 M
More Financials
Company
Galena Biopharma, Inc. is a biotechnology company focused on discovering, developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care.Its development portfolio ranges from mid to late stage clinical assets which include... 
Sector
Pharmaceuticals
Calendar
09/09 | 10:25amPresentation
More about the company
Surperformance© ratings of Galena Biopharma Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on GALENA BIOPHARMA INC
09/01 Galena Biopharma to Present at Two Upcoming Healthcare Investment Conferences
08/24 Galena Biopharma Announces Independent Data Safety Monitoring Committee Recom..
08/24 GALENA BIOPHARMA : Announces Independent Data Safety Monitoring Committee Recomm..
08/07 GALENA BIOPHARMA : Reports Second Quarter 2015 Financial Results
08/07 GALENA BIOPHARMA : Reports Second Quarter 2015 Financial Results
08/06 GALENA BIOPHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
08/06 GALENA BIOPHARMA : Results of Operations and Financial Condition, Regulation FD ..
08/06 Galena Biopharma Reports Second Quarter 2015 Financial Results
More news
Sector news : Pharmaceuticals - NEC
06:36a ASTRAZENECA : Signs Flu Vaccine Licensing Deal With Daiichi Sankyo
05:32a BAYER : New Real-World Evidence Reaffirms Low Major Bleeding Rates for Bayer's X..
05:32a AMGEN : UCB and Amgen announce positive top-line results from open-label study o..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/19 OCATA THERAPEUTICS : Insider Enrichment, Failed Science, Long History Of Fraud T..
08/06 Galena Biopharma's (GALE) CEO Mark Schwartz on Q2 2015 Results - Earnings Cal..
08/05 Notable earnings after Thursday?s close
07/30 Tesaro inks license deal with Jiangsu Hengrui for exclusive distribution of r..
07/30 PREMARKET BIOTECH DIGEST : Familial Hypercholesterolemia, Dynavax BLA Track, Ear..


Comments 
Advertisement
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | GALE | US3632561086 | 4-Traders
Full-screen chart
Technical analysis trends GALENA BIOPHARMA INC
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions